Breaking News

Over a week ago
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
ALKS

Alkermes

$44.02

-0.76 (-1.70%)

09:13
08/13/18
08/13
09:13
08/13/18
09:13
Recommendations
Alkermes analyst commentary at Jefferies »

Psychiatrists believe…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 04

    Sep

  • 31

    Jan

ALKS

Alkermes

$45.06

1.29 (2.95%)

07:34
08/07/18
08/07
07:34
08/07/18
07:34
Initiation
Alkermes initiated at Stifel »

Alkermes initiated with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 08

    Aug

  • 04

    Sep

  • 31

    Jan

ALKS

Alkermes

$45.06

1.29 (2.95%)

16:14
08/06/18
08/06
16:14
08/06/18
16:14
Initiation
Alkermes initiated at Stifel »

Alkermes initiated with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 08

    Aug

  • 04

    Sep

  • 31

    Jan

ALKS

Alkermes

$44.70

0.8 (1.82%)

08:06
07/27/18
07/27
08:06
07/27/18
08:06
Recommendations
Alkermes analyst commentary at Cantor Fitzgerald »

Alkermes story still…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 31

    Jan

ALKS

Alkermes

$43.90

-1.37 (-3.03%)

07:36
07/26/18
07/26
07:36
07/26/18
07:36
Hot Stocks
Alkermes preparing for ALKS 5461 advisory committee meeting in Q4 »

Alkermes said in this…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Jul

  • 31

    Jan

ALKS

Alkermes

$43.90

-1.37 (-3.03%)

07:24
07/26/18
07/26
07:24
07/26/18
07:24
Earnings
Alkermes backs FY18 non-GAAP EPS view of (6c)-12c, consensus 2c »

Backs FY18 revenue view…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Jul

  • 31

    Jan

ALKS

Alkermes

$43.90

-1.37 (-3.03%)

, BIIB

Biogen

$384.00

11.2 (3.00%)

07:22
07/26/18
07/26
07:22
07/26/18
07:22
Earnings
Alkermes reports Q2 EPS 29c, consensus 14c »

Reports Q2 revenue…

ALKS

Alkermes

$43.90

-1.37 (-3.03%)

BIIB

Biogen

$384.00

11.2 (3.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Jul

  • 30

    Jul

  • 31

    Jul

  • 31

    Jan

Over a month ago
ALKS

Alkermes

$45.29

0.31 (0.69%)

09:00
07/20/18
07/20
09:00
07/20/18
09:00
Recommendations
Alkermes analyst commentary at B. Riley FBR »

Alkermes remains a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Jul

  • 31

    Jan

ALKS

Alkermes

$44.85

0.58 (1.31%)

11:41
07/16/18
07/16
11:41
07/16/18
11:41
Hot Stocks
Alkermes awarded contract worth $186.35M from Department of Veterans Affairs »

Alkermes was awarded a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 31

    Jan

ALKS

Alkermes

$41.41

0.26 (0.63%)

10:55
07/02/18
07/02
10:55
07/02/18
10:55
Hot Stocks
Alkermes CEO calls today's Aristada Initio approval important »

Alkermes CEO Richard Pops…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 31

    Jan

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.